Skip to main content

Day: June 14, 2022

Bimbo Bakeries USA Publishes 2021 Diversity, Equity & Belonging Report

Report Highlights Company’s Accomplishments in 2021 And Introduces Three-Year Goals and Commitments HORSHAM, Pa., June 14, 2022 (GLOBE NEWSWIRE) — Bimbo Bakeries USA (BBU) today published its 2021 Diversity, Equity & Belonging report, Our Foundation of Belonging. It highlights BBU’s 2021 accomplishments in its strategic framework of Workforce, Workplace and Marketplace and introduces three-year goals and commitments. Bimbo Bakeries USA is a proud part of Grupo Bimbo, the world’s largest baking company, who is committed to advancing Diversity, Equity and Belonging in all 33 countries where it operates. BBU’s 2021 Diversity, Equity & Belonging Report acknowledges the work accomplished since establishing a Diversity, Equity & Belonging function in early 2021. Highlights from the report include:Racial Equity Action...

Continue reading

UPS Welcomes Bala Subramanian to Newly Created Position of EVP and Chief Digital and Technology Officer

ATLANTA, June 14, 2022 (GLOBE NEWSWIRE) — UPS (NYSE: UPS) today appointed Bala Subramanian, 50, to the newly created position of Executive Vice President and Chief Digital and Technology Officer. Effective July 18, Bala will report to Chief Executive Officer Carol B. Tomé and join the UPS Executive Leadership Team with responsibility for technology and industrial engineering to drive more innovative, agile and flexible solutions for UPS stakeholders. “Bala will supercharge our digital transformation at UPS, driving new competitive advantages for our customers and partners,” said Carol. “He will be laser focused on making it easier to do business with UPS, while giving our employees new tools to unleash even more innovation for our customers.” In this new role, Bala will be responsible for the overall strategy, design, development...

Continue reading

Ålandsbanken Abp: Acquisitions of own shares 14.06.2022

Ålandsbanken Abp  Changes in company’s own shares 14.06.2022 at 18:30 EET   Ålandsbanken Abp: Acquisitions of own shares 14.06.2022  Date 14.06.2022  Exchange Bourse trade Nasdaq Helsinki Oy (XHEL) Buy  Share class ALBBV  Amount         677  Average price/share 29.7000 EURHighest price/share 29.7000 EURLowest price/share 29.7000 EURTotal price 20,106.90 EUR       The shares held by Ålandsbanken Abp on 14.06.2022:    ALBBV 9,942      On behalf of Ålandsbanken Abp Skandinaviska Enskilda Banken AB (Publ)     Antti Salakka         Janne Tiihonen     For more information, please contact: Peter Wiklöf, Managing Director and Chief Executive, Bank of Åland Plc, tel +358 40 512 7505  AttachmentALBBV SBB 14062022

Continue reading

Presents accelerated production growth strategy, plans organic investment programme, and announces agreement to acquire participation in a block in the prolific Vaca Muerta shale basin in Argentina

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. 14 June 2022 Interoil Exploration and Production ASA (the “Company”) is pleased to announce its accelerated growth strategy with the objective to deliver strong production growth. This strategy will be underpinned by organic growth and acquisitions. The Company will invest in organic growth by re-opening shut-in wells in its Santa Cruz portfolio, Mata Magallanes Oeste (“MMO”) and La Brea. Further, the Company has developed a deal pipeline which will allow the Company to consolidate its portfolio in Santa Cruz and establish beachheads for future growth in other prolific basins. The company has entered into...

Continue reading

South Africa grants Lleida.net its 211th patent

MADRID, Spain, June 14, 2022 (GLOBE NEWSWIRE) — The South African Patent Office (CIPC Companies and Intellectual Property Commission) has granted the Spanish-listed company Lleida.net (BME:LLN; EPA:ALLLN; OTCQX:LLEIF) a new patent for its method of certifying text messages. This is the second patent that the Spanish company has received from the South African authorities and is valid for 20 years. This brings to 211 the number of patents that the company has received globally for its registered notification, contracting, and electronic signature methods. To date, more than 60 countries on five continents have recognized the company’s inventions in what is the industry’s largest intellectual property portfolio in Europe. These include the European Union, the United States, China, Russia, India, Mexico, Japan, Colombia,...

Continue reading

Camposol Holding PLC reports first quarter 2022 preliminary financial results

  CSOL Holding’s 2022-1Q LTM EBITDA from continuing operations amounted to USD 121.6 million and the corresponding EBITDA margin was 30%. Sales amounted to USD 406.3 million, up 11.7% compared to 2021-1Q LTM, explained mainly due to increases in blueberries volumes. As of March 31st, 2022, the Company maintained a cash balance of USD 35.5 million and a net leverage ratio of 3.5x. The Company continues executing its strategy to become a year-round supplier of fresh fruit to our global clients complementing its Peruvian window operations with investments in Colombia, Uruguay and lately in Chile, and capitalizing on its commercial and logistic platforms. Please see the first quarter financial results’ report enclosed (or click on the link below of this release if received by e-mail). For further information, please contact: Milagritos...

Continue reading

Cogstate Announces Formation of Scientific Advisory Board

Leading clinical and scientific experts in neurodegenerative diseases and pharmaceutical research will provide guidance to progress Cogstate’s strategy Melbourne, VIC, Australia; New Haven, CT, USA, June 14, 2022 (GLOBE NEWSWIRE) — Cogstate (ASX.CGS) a leading neuroscience technology company, today announced the formation of a Scientific Advisory Board (SAB), comprising clinical and scientific experts in cognitive assessment and drug development. The SAB will work closely with the Cogstate scientific leadership team to support the advancement of the company’s strategy, innovation roadmaps, and research & development initiatives.     The SAB will be chaired by Eric Siemers, MD, whose clinical trial experience spans 25 years including serving as the Distinguished Medical Fellow for Eli Lilly and Company’s Alzheimer’s Disease...

Continue reading

Adial Pharmaceuticals Awarded Additional U.S. Patent Combining the Use of the Company’s Proprietary Genetic Diagnostic With AD04 to Treat Alcohol and Drug Dependence

New patent covers the use of the full genetic panel measuring all five genetic biomarkers CHARLOTTESVILLE, Va., June 14, 2022 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced patent number 11,351,154 was issued on June 7, 2022, by the U.S. Patent and Trademark Office. The patent covers the use of the Company’s genetic diagnostic panel in combination with the Company’s lead product, AD04, for the treatment of alcohol use disorder (AUD) and Opioid Use Disorder (OUD). This patent expands coverage of previously issued patents to include the measurement of the genetic biomarkers for all of the targeted genotypes utilizing the Company’s...

Continue reading

Scilex Holding Company, a Sorrento Company, enters into an agreement for an exclusive license with ROMEG Therapeutics, LLC, for the right to commercialize Gloperba®, an FDA-approved prophylactic treatment for painful gout flares in adults, in the US.

Gloperba is an FDA-approved, oral medication for treating painful gout flares in adults. Gout is a painful arthritic disorder affecting an estimated 8.7 million people in the United States1. As gout cases increase every year, treatment requirements increase. The gout treatment market is large and projected to be $8.3 billion in the US by 2025 and has a compound annual growth rate of 16% with a well-defined area of unmet need. Scilex is well-positioned to market and distribute Gloperba:Scilex has a direct distribution network to national and regional wholesalers and pharmacies throughout all US states. Scilex has a very experienced commercial and managed care team that has successfully launched and grown market access for ZTlido (lidocaine topical system) to about 200 million covered lives in the US.PALO ALTO, Calif., June 14, 2022...

Continue reading

IQST – iQSTEL Announces 39% YTD Revenue Growth Through May To $33 Million

New York, NY, June 14, 2022 (GLOBE NEWSWIRE) — iQSTEL, Inc. (OTCQX: IQST) today announced the company’s revenue for the month of May is $6.9 million based on preliminary accounting. The company’s year-to-date (YTD) revenue through the end of May based on the preliminary accounting is over $33 million representing an increase of 39% over the approximate $24 million realized in the same period the previous year. Beginning this month in June, iQSTEL will start to realize the revenue generated by the recent Smartbiz and Whisl acquisitions.  Combined, the two acquisitions are anticipated to add $11.6 million in annual revenue and $1.34 million in positive net income. The iQSTEL Q2 and Q3 financial reports will reflect the contribution of the two acquisitions. The company continues to work on the recently announced opportunity to add...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.